This study indicates that SphK1 contributes to metastatic progression of colon cancer by triggering EMT via up-regulation of MMP2/9 expression accompanied by activation of FAK/AKT signaling pathways [57]. This evidence concerns the gene PTK2 and malignant colon neoplasm.